Project Grant HT94252410756
- The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- The U.S. Defense Health Agency awarded a $1,312,000.00 Project Grant to the Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective August 1, 2025 through July 31, 2029, supports research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. As a prominent academic medical center and research institution, UCSF will leverage its expertise in...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.97M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports the development of CD46-targeted antibody fragment radiopharmaceutical therapy for prostate cancer treatment. This research initiative represents a translational medicine effort to advance diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $328,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2027. The award funds research on intracranial drug delivery strategies targeting skull bone marrow to generate antitumoral myeloid cell immune responses against glioblastoma. This research initiative represents UCSF's...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $750,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective March 1, 2026, through February 28, 2029. The grant supports research on the use of dimeric immunoglobulin A as a therapeutic approach to treat breast cancer, with work to be conducted at UCSF's San Francisco, California facility. This three-year award represents...
- This $2,377,839 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by The Regents of the University of California, San Francisco (UCSF) to develop evidence-based approaches for predicting cardiovascular risk in immune-mediated inflammatory diseases. The 4-year project, running from June 1, 2025 to May 31, 2029, aims to transform healthcare for military service members, veterans, and the...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,226,730 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award funds research investigating the canonical Polycomb Repressive Complex 1 (cPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This hypothesis-driven research initiative...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
This $300,000 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The award is intended to support research focused on "Identifying Regulators of Extrafollicular Plasma Cell Differentiation" over the July 2024 to July 2026 performance period. As a leading academic medical center, UCSF will leverage its expertise in biomedical research to conduct innovative scientific studies aimed at advancing knowledge and treatments in this area. The federal grant funding will enable UCSF researchers to carry out basic, translational, and potentially clinical investigations to better understand the biological mechanisms underlying plasma cell development, with the goal of improving healthcare outcomes for military personnel and the broader population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $300.0k | 7/8/24 |